Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (31)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Suikkari, A.-M.
Right arrow Articles by Barnes, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suikkari, A.-M.
Right arrow Articles by Barnes, F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 15, No. 4, 747-751, April 2000
© 2000 European Society of Human Reproduction and Embryology

Luteal phase start of low-dose FSH priming of follicles results in an efficient recovery, maturation and fertilization of immature human oocytes

Anne-Maria Suikkari1,4, Maija Tulppala1, Timo Tuuri1, Outi Hovatta2 and Frank Barnes3

1 The Family Federation of Finland, Infertility Clinic, Helsinki, Finland, 2 Huddinge Sjukhus, Karolinska Institute, Stockholm, Sweden and 3 Pacific Fertility Medical Center, Westwood Medical Plaza, Los Angeles, California, USA

In this prospective study we investigated whether the maturation and fertilization of immature oocytes can be improved by administration of recombinant follicle stimulating hormone (rFSH) starting in the late luteal phase in two groups of women: group 1 (n = 6) women with regular menstrual cycles; and group 2 (n = 6) women with irregular cycles and polycystic ovaries (PCO) on ultrasound examination. Low-dose (37.5 IU) rFSH was commenced 11 days after LH surge during a spontaneous menstrual cycle and on the ninth day of progesterone administration in an irregular cycle. Recombinant FSH was continued until the leading follicle was approximately 10 mm in diameter. The oocytes were retrieved after withdrawing rFSH for 2–5 days. In total, 136 oocytes were recovered (group 1, 67 oocytes; group 2, 69 oocytes). Nine of the oocytes from PCO women were atretic at retrieval. Oocytes complete with cumulus cells were cultured for 44 h in complex tissue culture medium supplemented with gonadotrophins and fetal calf serum. After maturation, the cumulus cells were removed and metaphase II oocytes were injected with spermatozoa. Respectively, the oocyte maturation and fertilization rates were 64 and 72% in group 1, and 78 and 57% in group 2 (not significant). After fertilization, the zygotes (group 1, n = 22; group 2, n = 11) and cleavage stage embryos (group 1, n = 9; group 2, n = 15) were frozen in propanediol. All women except one (11/12) had approximately five zygotes or cleaved embryos frozen. The viability of in-vitro matured frozen–thawed embryos was generally poorer than that (81%) seen after conventional intracytoplasmic sperm injection, with 61% survival in group 1 and 23% in group 2. Fifteen embryo transfers resulted in one miscarriage at 6 weeks gestation. The late luteal start of low-dose rFSH yielded a good number of immature oocytes in women with both regular and irregular cycles. Two out of three of these oocytes matured and fertilized. However, cryosurvival of the zygotes and cleaved embryos was unsatisfactory and thus cryopreservation of in-vitro matured embryos may not be an optimal procedure.

Key words: FSH/immature oocytes/in-vitro maturation/minimal stimulation

4 To whom correspondence should be addressed at: Infertility Clinic, The Family Federation of Finland, PO Box 849, 00101 Helsinki, Finland


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum ReprodHome page
V. Soderstrom-Anttila, S. Makinen, T. Tuuri, and A.-M. Suikkari
Favourable pregnancy results with insemination of in vitro matured oocytes from unstimulated patients
Hum. Reprod., June 1, 2005; 20(6): 1534 - 1540.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J. Hreinsson, B. Rosenlund, B. Friden, L. Levkov, I. Ek, A.-M. Suikkari, O. Hovatta, and M. Fridstrom
Recombinant LH is equally effective as recombinant hCG in promoting oocyte maturation in a clinical in-vitro maturation programme: a randomized study
Hum. Reprod., October 1, 2003; 18(10): 2131 - 2136.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
P. Zheng, W. Si, B. D. Bavister, J. Yang, C. Ding, and W. Ji
17{beta}-Estradiol and progesterone improve in-vitro cytoplasmic maturation of oocytes from unstimulated prepubertal and adult rhesus monkeys
Hum. Reprod., October 1, 2003; 18(10): 2137 - 2144.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
Y.-H. Lin, J.-L. Hwang, L.-W. Huang, S.-C. Mu, K.-M. Seow, J. Chung, B.-C. Hsieh, S.-C. Huang, C.-Y. Chen, and P.-H. Chen
Combination of FSH priming and hCG priming for in-vitro maturation of human oocytes
Hum. Reprod., August 1, 2003; 18(8): 1632 - 1636.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.